SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-064272
Filing Date
2020-12-18
Accepted
2020-12-18 10:39:43
Documents
1
Period of Report
2020-12-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3069
  Complete submission text file 0001209191-20-064272.txt   4652
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Issuer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address MEIERHOFSTRASSE 5 LIECHTENSTEIN N2 9490 VADUZ
Business Address MEIERHOFSTRASSE 5 LIECHTENSTEIN N2 9490 VADUZ 423 237 11 11
BAY STREET FINANCIAL S.A. (Reporting) CIK: 0001803399 (see all company filings)

State of Incorp.: R1 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37347 | Film No.: 201398416